A detailed history of Vanguard Group Inc transactions in Seer, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,636,577 shares of SEER stock, worth $4.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,636,577
Previous 2,610,633 0.99%
Holding current value
$4.43 Million
Previous $5.06 Million 1.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.54 - $2.09 $39,953 - $54,222
25,944 Added 0.99%
2,636,577 $5.01 Million
Q4 2023

Feb 14, 2024

BUY
$1.47 - $2.22 $186,037 - $280,954
126,556 Added 5.09%
2,610,633 $5.06 Million
Q3 2023

Nov 14, 2023

BUY
$2.18 - $5.52 $15,985 - $40,478
7,333 Added 0.3%
2,484,077 $5.49 Million
Q2 2023

Aug 14, 2023

BUY
$3.16 - $4.96 $38,548 - $60,507
12,199 Added 0.49%
2,476,744 $10.6 Million
Q1 2023

May 15, 2023

SELL
$3.6 - $5.88 $3.6 Million - $5.89 Million
-1,001,085 Reduced 28.89%
2,464,545 $9.51 Million
Q4 2022

Feb 10, 2023

SELL
$5.03 - $8.58 $4.84 Million - $8.25 Million
-961,558 Reduced 21.72%
3,465,630 $20.1 Million
Q3 2022

Nov 14, 2022

BUY
$7.7 - $13.31 $285,315 - $493,188
37,054 Added 0.84%
4,427,188 $34.3 Million
Q2 2022

Aug 12, 2022

BUY
$6.72 - $16.07 $1.17 Million - $2.8 Million
174,306 Added 4.13%
4,390,134 $39.3 Million
Q1 2022

May 13, 2022

SELL
$11.88 - $23.4 $69,759 - $137,404
-5,872 Reduced 0.14%
4,215,828 $64.2 Million
Q4 2021

Feb 14, 2022

BUY
$21.08 - $38.51 $9.14 Million - $16.7 Million
433,495 Added 11.44%
4,221,700 $96.3 Million
Q3 2021

Nov 12, 2021

BUY
$27.67 - $45.04 $80.2 Million - $131 Million
2,899,279 Added 326.16%
3,788,205 $131 Million
Q2 2021

Aug 13, 2021

BUY
$28.75 - $56.92 $25.6 Million - $50.6 Million
888,926 New
888,926 $29.1 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.